← Leaderboards
Zachary Alan Levine
Yale University
$661,934
Attributed
$1,070,058
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $538.5K · FY2020–21$1M$750K$500K$250K$0
'20
'21
Funding mix
By agency
NIH$1,070,058 · 2
By mechanism
R01$816,248 · 1
K01$253,810 · 1
Top collaborators
- Morgan Elyse Levine2 shared
Most similar at Yale University
Same institution · by research overlap
- Stephen M Strittmatter$76,187,371
- Ruth R Montgomery$17,255,276
- Tian Xu$6,161,735
- Rong Fan$22,943,481
- Yiyun Henry Huang$18,008,787
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseBrainLipidsPathologicSamplingIn VitroExperimental StudyIn VivoLinkMolecularNerve DegenerationAnimal ModelPhysiologicalMembrane ProteinsBiophysicsAbeta OligomerCellsBaseAmyloidBindingAge RelatedAffectSeverity Of Illness
Grant awards (4)
AMYLOIDOGENIC INDUCTION OF CELLULAR SENESCENCE IN ALZHEIMER'S DISEASE$404,248
R01 · FY2021 · AG
REPURPOSING PRION PROTEINS AS TRANSLATIONAL AMYLOID-TARGETING THERAPEUTICS FOR ALZHEIMER'S DISEASE$127,305
K01 · FY2021 · AG · contact PI
AMYLOIDOGENIC INDUCTION OF CELLULAR SENESCENCE IN ALZHEIMER'S DISEASE$412,000
R01 · FY2020 · AG
REPURPOSING PRION PROTEINS AS TRANSLATIONAL AMYLOID-TARGETING THERAPEUTICS FOR ALZHEIMER'S DISEASE$126,505
K01 · FY2020 · AG · contact PI